Mandate

VINGE ADVISES CORESEC SYSTEMS HOLDING AB

May 05, 2015

Vinge has advised Coresec Systems Holding AB, which is majority-owned by Perusa Partners Fund 2 L.P., in connection with its acquisition of the Swedish IT security company ISecure Sweden AB.

Vinge’s team consisted of responsible counsel Ulrich Ziche together with associates Johan Steen, Mårten Svensson and Andrea Jägerstad (M&A), partner Karin Grauers (commercial agreements, etc.), associates Åsa Gotthardsson and Tomas Forsgren (employment), Helena Höök and Johan Wahlbom (public procurement and competition) as well as Mathilda Gustafsson (real estate). Partner Mikael Ståhl and associate Lynn Adewald provided financing advice.

For further information, see Coresec’s press release: http://www.coresec.se/news/

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024